Media is biomanufacturing’s untapped advantage.
More medicines, materials and foods are now made with cells, and every one of them depends on the media those cells grow in. At the same time, patent expiries, regulatory reform and on-shored supply chains are pushing manufacturers to make more, for less, more reliably. Every one of those pressures runs through cell culture media.
Yet media has been left behind, because developing it is intrinsically hard. A typical formulation contains 60+ interacting ingredients, and at just three concentration levels each, there are more possible combinations than grains of sand on Earth. Conventional labs can test only a tiny fraction, so most media remain under-optimised. To resolve these pressures, how we think about media has to fundamentally change.
Three pressures are converging. Media is a lever on all three.
of US biologic sales lose exclusivity by 2034, about twelve biologics a year1
of FDA rejections since 2020 trace to inadequate media2
Critical manufacturing is moving closer to home, so every media ingredient needs a reliable supply at scale
Media design hasn't kept pace.
of biomedical research still runs on formulations designed in the 1950s and 1960s3
interacting ingredients in a full formulation
possible formulations from 40 ingredients at five levels, too many to search by trial and error
- 1. IQVIA Institute (2025)
- 2. Pazhayattil et al., ISPE (2024)
- 3. Cox et al. (2020)
Media is a data problem. MediOP™ is built to solve it.
Finding the right formulation means testing far more combinations than any lab can run by hand, leaving traditional media development to chance. Our MediOP™ platform combines data, models, and design iteratively by integrating high-throughput robotic automation, AI, and deep cell biology expertise. Leveraging our platform, we have built the first data-driven design process for cell culture media. Unlike conventional approaches, we can generate rich performance data at scale, unlocking the potential of cell-based biomanufacturing.
Inside MediOP™- 01
Design
Formulations proposed against the cell line in front of us, not tweaks to an off-the-shelf recipe.
Up to 100 interacting ingredients per formulation - 02
Test
Robotics prepare unique formulations in parallel, and plates cycle through incubation on schedule.
AI readout03Read
Every well imaged and segmented, so MediOP™ can interpret what the cells require.
- 0data points+~200k every cycle04
Learn
Results train the model and set the next design. Every run makes the next one faster.
8M+ data points generated by MediOP™
Better media means better biomanufacturing.
Better media unlocks the next wave of innovation across therapeutics, food and advanced materials. We're partnering with industry leaders to accelerate biomanufacturing breakthroughs and unlock their cells' potential.